Clinical Trials Directory

Trials / Completed

CompletedNCT01514591

Thromboelastography in Non-elective Cesarean Delivery

Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Detailed description

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). TEG is a point- of-care device which measures the viscoelastic properties of clot formation. This device can provide rapid and detailed information about coagulation changes in the perioperative period. We will compare coagulation data collected from the study to assess potential coagulation changes associated with Hemoglobin changes before and after surgery, and related to estimated blood loss.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2012-01-23
Last updated
2013-06-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01514591. Inclusion in this directory is not an endorsement.